#1 Clinical Trials Search in Europe

Methotrexate Sodium

This article delves into recent clinical trials investigating the use of Methotrexate Sodium, a widely used medication. These studies focus on understanding drug interactions with Methotrexate and its application in treating specific medical conditions. The trials aim to improve our knowledge of how Methotrexate works in combination with other drugs and its effectiveness in certain treatments.

Table of Contents

What is Methotrexate Sodium?

Methotrexate Sodium is a medication that belongs to a class of drugs known as antimetabolites. It’s a versatile drug used in the treatment of various conditions, ranging from certain types of cancer to autoimmune disorders. Methotrexate works by interfering with the growth of certain cells in the body, particularly those that multiply quickly.[1]

Uses of Methotrexate Sodium

Methotrexate Sodium is used to treat several medical conditions, including:

  • Ectopic Pregnancy: This is a serious condition where a fertilized egg implants outside the uterus, usually in the fallopian tube. Methotrexate is used as a medical treatment for early cases of ectopic pregnancy, helping to avoid surgery in some cases.[2]
  • Certain Types of Cancer: While not explicitly mentioned in the provided trials, Methotrexate is known to be used in the treatment of various cancers.
  • Autoimmune Disorders: Although not directly stated in the given trials, Methotrexate is commonly used to treat conditions like rheumatoid arthritis and psoriasis.

How Methotrexate Sodium is Administered

Methotrexate Sodium can be administered in different ways, depending on the condition being treated and the specific treatment plan:

  • Oral Administration: Methotrexate can be taken by mouth in tablet form.[1]
  • Intramuscular Injection: For certain conditions, like ectopic pregnancy, Methotrexate may be given as an intramuscular (IM) injection. In one study, a single dose of 100 mg was used.[2]

Drug Interactions with Methotrexate Sodium

Methotrexate Sodium can interact with other medications, potentially affecting its effectiveness or increasing the risk of side effects. Some notable interactions include:

  • Rifampicin: This is an antibiotic used to treat various bacterial infections, including tuberculosis. Studies are being conducted to understand how Rifampicin affects the way Methotrexate works in the body.[1][3]
  • Febuxostat: This medication is used to treat gout. Research is ongoing to determine how Febuxostat might interact with Methotrexate.[3]

Understanding Pharmacokinetics of Methotrexate

Pharmacokinetics refers to how a drug moves through the body. For Methotrexate, researchers are studying several aspects:

  • Cmax (Maximum Concentration): This is the highest level of the drug in the blood after it’s administered.[1][3]
  • AUClast (Area Under the Curve to last measurable time point): This measure helps understand how much of the drug is in the body over time.[1][3]
  • AUCinf (Area Under the Curve from 0 hours to infinite time): This provides information about the total exposure to the drug over time.[1][3]

Researchers are also studying a compound called 7-hydroxy methotrexate, which is formed when the body processes Methotrexate.[1][3]

Potential Side Effects and Monitoring

While specific side effects are not mentioned in the provided trials, it’s important to note that all medications can have side effects. When taking Methotrexate, patients are typically monitored closely. For example, in the treatment of ectopic pregnancy, doctors measure levels of a hormone called beta-hCG (beta human chorionic gonadotropin) to track the effectiveness of the treatment.[2]

Always consult with your healthcare provider about potential side effects and necessary monitoring when taking Methotrexate or any other medication.

Study Focus Drugs Involved Primary Outcomes Patient Group
Drug interaction with Rifampicin Methotrexate, Rifampicin Cmax, AUClast, AUCinf of Methotrexate Elderly subjects
Ectopic Pregnancy Treatment Methotrexate, Letrozole Beta-hCG levels reduction Women with early ectopic pregnancy
Drug interaction with Rifampicin and Febuxostat Methotrexate, Rifampicin, Febuxostat Cmax, AUClast, AUCinf of Methotrexate Healthy subjects

FAQ

  • What is the main purpose of the clinical trials involving Methotrexate Sodium? The main purposes are to investigate drug interactions between Methotrexate and other medications (such as rifampicin and febuxostat) and to evaluate its effectiveness in treating certain conditions like ectopic pregnancy.
  • How is Methotrexate being compared to other treatments in these trials? In one trial, Methotrexate is being compared to Letrozole for the treatment of early ectopic pregnancy. The study aims to determine if Letrozole is non-inferior to Methotrexate in this application.
  • What are the primary outcomes being measured in these trials? The primary outcomes include comparing the maximum concentration (Cmax), area under the plasma concentration-time curve (AUClast and AUCinf) of Methotrexate when used alone and in combination with other drugs. In the ectopic pregnancy trial, the primary outcome is the reduction in beta-hCG levels.
  • Are there any specific patient groups involved in these trials? Yes, one trial specifically focuses on elderly subjects to evaluate drug interactions. Another trial involves women with early ectopic pregnancy who are hemodynamically stable. There's also a trial involving healthy subjects.
  • What forms of Methotrexate are being used in these trials? The trials use different forms of Methotrexate administration. Some use oral Methotrexate, while others use intramuscular injection. The specific form depends on the trial design and the condition being studied.

Ongoing Clinical Trials on Methotrexate Sodium

  • Study of Blinatumomab and a drug combination for older adults with newly diagnosed Philadelphia-negative B-cell precursor Acute Lymphoblastic Leukemia

    Recruiting

    1 1 1 1
    Investigated drugs:
    Austria Belgium Bulgaria Czechia Denmark Estonia +11

  • Study of Avacopan Safety and Effectiveness in Patients with ANCA-associated Vasculitis

    Recruiting

    1 1 1
    Investigated drugs:
    Czechia Denmark France Greece Hungary Poland +1

  • Study on Baricitinib for Patients with Calcium Pyrophosphate Deposition Disease (CPPD) Using Methotrexate Sodium and Drug Combination

    Recruiting

    1 1 1
    Investigated drugs:
    Italy

  • Study on Lymphoblastic Lymphoma Treatment in Children and Adolescents Using Dexamethasone, Prednisone, and PEG-Asparaginase

    Recruiting

    1 1 1 1
    Investigated drugs:
    Austria Belgium Czechia Denmark Finland Germany +8

  • Study of KYV-101 Therapy for Patients with Refractory Generalized Myasthenia Gravis

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Germany

  • Study on the Safety and Effectiveness of Fludarabine and Treosulfan for Stem Cell Transplant in Acute Myeloid Leukemia Patients Aged 40 to 65

    Not yet recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Italy

  • Study Comparing Conventional Therapy and Biologic Treatments for Early Rheumatoid Arthritis Using Hydroxychloroquine, Abatacept, and Azathioprine in Responsive Patients

    Not yet recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark Iceland Norway Sweden

  • A study to evaluate the efficacy and safety of vixarelimab in patients with moderate to severe ulcerative colitis

    Not recruiting

    1 1
    Investigated drugs:
    Belgium Czechia France Germany Greece Italy +1

  • Study on Methotrexate and Phototherapy for Adults with Progressive Vitiligo

    Not recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    France

  • Study on Improving Treatment for Children and Adolescents with Acute Lymphoblastic Leukemia Using Bortezomib, Blinatumomab, and a Drug Combination

    Not recruiting

    1 1 1 1
    Investigated drugs:
    Austria Czechia Germany Italy Slovakia

Glossary

  • Pharmacokinetics: The study of how a drug moves through the body, including its absorption, distribution, metabolism, and excretion.
  • Cmax: The maximum concentration of a drug in the blood after it has been administered.
  • AUClast: Area Under the Curve to last measurable time point, which represents the total exposure to a drug over time.
  • AUCinf: Area Under the Curve from 0 hours to infinite time, representing the total exposure to a drug over an infinite time period.
  • Beta-hCG: Beta human Chorionic Gonadotropin, a hormone produced during pregnancy that is measured to monitor ectopic pregnancies.
  • Ectopic Pregnancy: A pregnancy where the fertilized egg implants outside the uterus, often in the fallopian tube.
  • Hemodynamically stable: A condition where a patient's blood circulation is functioning well without significant issues.
  • Aromatase inhibitor: A type of drug that lowers estrogen levels in the body, used in some cancer treatments and potentially in treating ectopic pregnancy.
  • Drug-drug interaction: When one drug affects the activity of another drug when both are used together, potentially changing their effectiveness or side effects.

References

  1. https://clinicaltrials.gov/study/NCT06108453
  2. https://clinicaltrials.gov/study/NCT06354439
  3. https://clinicaltrials.gov/study/NCT05575297